Introduction
Candida albicans systemic infections have an important impact on the clinical course and outcomes of cancer patients [1, 2] , as they are responsible for prolonged hospital stays, high healthcare costs and significant mortality [3] [4] [5] [6] . Several authors have disagreed with the widely held belief that compromised immune responses are a cause of the susceptibility to infection in tumour patients, and they have reported that the tumoral condition can generate a protective response against this pathogen [7] . Considering that this phenomenon could be associated with the activation state of macrophages, we decided to study this premise using peritoneal macrophages.
Macrophages have been recognized as a critical component of the innate immune system and can regulate both the immune response against micro-organisms and the development of a solid tumour [8] . We chose to use peritoneal macrophages because macrophages have been shown to traffic between the peritoneum and neoplastic tissues [9, 10] . According to those authors, the peritoneal cavity may act as a training ground where macrophages undergo developmental changes in response to several stimuli. To our knowledge, there have been no previous reports with a simultaneous examination of candidiasis on Ehrlich solid tumour mice and the role of macrophage activity in this process. The Ehrlich solid tumour model was chosen because the majority of knowledge concerning Candida infections in cancer patients has been obtained from patients with haematological malignancies and candidaemia has been an important complication in patients with solid tumour [6] .
Materials and methods
Animals. All protocols are in accordance with the ethical principles for animal research adopted by the Brazilian College of Animal Experimentation (COBEA). Twomonth-old male Swiss mice were obtained from the Animal House of Sao Paulo State University, Botucatu, SP, Brazil. Mice were housed in groups of three to five animals and were provided with food and water ad libitum.
Experimental design. Mice were divided into four groups: tumour-bearing mice that were inoculated with C. albicans (Ca-TBM), uninoculated tumour-bearing mice (TBM), C. albicans-inoculated control mice (Ca-CTL), and uninoculated naive mice (CTL). Mice from the TBM group were killed on days 7, 14 and 21 to analyse certain parameters. The Ca-TBM group was inoculated intraperitoneally (i.p.) with C. albicans (5 · 10 6 fungi) on days 7, 14 and 21 following tumour implantation and was killed after 24 and 72 h of C. albicans inoculation. Finally, the Ca-CTL group was killed 24 and 72 h following C. albicans inoculation.
Solid Ehrlich tumour. This neoplasia, which is a spontaneous mammary tumour in mice, does not resolve spontaneously. It may evolve to the ascitic or solid forms depending on the route of inoculation [i.p. or subcutaneous (s.c.) respectively] [11] . For our studies, the tumour was maintained in the ascitic form in Swiss mice and tumour cells were collected according to the methods of Silva et al. [12] . 1 · 10 7 tumour cells ⁄ 100 ll were inoculated s.c. in both TBM and Ca-TBM mice.
Candida albicans inoculum. Candida albicans strain FCF-14 was originally obtained from the fungal collection of the School of Odontology, Sao Paulo State University, Sao Jose dos Campos, SP, Brazil. The fungi were maintained on Sabouraud medium (Difco Lab., Detroit, MI, USA). To prepare the inoculum, fungi were cultured in Sabouraud medium for 24 h at 37°C and the colonies were resuspended and washed twice. The fungal viability was determined by cotton blue staining, and the final concentration was adjusted to 5 · 10 7 viable C. albicans ⁄ ml [13] . Collection of the biological material and macrophage culture. Mice were killed using CO 2 euthanasia, and the peritoneal cells were collected by washing the peritoneal cavity with 10 ml sterile ice-cold phosphate-buffered saline, pH 7.4. The suspension was then centrifuged and the cells were resuspended in 1 ml RPMI-1640 medium (Nutricell, Campinas, SP, Brazil) containing 10% heat inactivated foetal calf serum (Gibco BRL, Grand Island, NY, USA). The cell concentration was adjusted to 2 · 10 6 macrophages ⁄ ml, as judged by 0.02% neutral red uptake. The peritoneal cells were placed in 96-well flat-bottom microtitre plates (Costar, Cambridge, MA, USA) and incubated for 2 h at 37°C and 5% CO 2 , in a humidified chamber to allow macrophages to adhere and spread. Non-adherent cells were removed by washing the wells three times with RPMI and the remaining adherent cells (>97% macrophages as assessed by morphological examination) were used to perform the experiments. The macrophages were cultured in RPMI-1640 with or without 10 lg ⁄ ml LPS (Sigma, St Louis, MO, USA), as an internal control of macrophage activity (data not shown), at 37°C and 5% CO 2 . After 24 h, the cell-free supernatants were harvested and stored at )70°C to posterior NO and TNF-a analysis. Finally, the peritoneal fluid and liver, spleen and kidney fragments were submitted to microbiological evaluation.
Direct organ culture. For organ cultures, 10 fragments (2 · 2 mm) of liver, spleen and kidney were placed on 15 · 90 mm Sabouraud agar plates at 37°C for 5 days, as described previously [14] . The yeast colonies present on the organ fragments were counted and the results were expressed as the frequency of Candida-positive organ fragments.
Fungal loads in peritoneal lavage (PL). Peritoneal lavage fluid samples (30 ll) were placed on 15 · 90 mm Sabouraud agar plates at 37°C. The yeast colonies were counted after 5 days and the fungal loads were expressed as colony-forming units (CFU).
Nitric oxide production. To determine NO levels, the production of nitrite (a stable end product of NO) was measured in the cell-free supernatants of cultured macrophages according to the methods of Green et al. [15] . Briefly, 100 ll of the cell-free supernatant was incubated with an equal volume of Griess reagent containing 1% sulfanilamide (Synth, Diadema, SP, Brazil), 0.1% naphthylene diamine dihydrochloride (Sigma) and 2.5% H 3 PO 4 , at room temperature for 10 min and the nitrite accumulation was quantified using an ELISA microreader (ELx 800; Bio-tek Instruments Inc., Winooski, VE, USA). The concentration of nitrite was determined using sodium nitrite (Sigma) diluted in RPMI-1640 medium as a standard.
Hydrogen peroxide release (H 2 O 2 ). Macrophages (2 · 10 6 cells ⁄ ml) were obtained as described before and were maintained in RPMI-1640 culture medium at 37°C and 5% CO 2 for 24 h. At the end of the cell culture period, the supernatant was removed and macrophages were incubated with phenol red solution [dextrose (Sigma), phenol red (Sigma), horseradish peroxidase type II (Sigma)] and plated at 37°C in 5% CO 2 for 1 h according to the methods of Russo et al. [16] . The reaction was stopped with the addition of 1 N NaOH and the H 2 O 2 concentration was determined using an ELISA microreader. TNF-a analysis. TNF-a levels in cell-free supernatant were quantified using the Cytokine Duo-Set Kit (R&D Systems, Minneapolis, MI, USA) according to the manufacturer's instructions.
Statistical analysis. The peritoneal microbiological data were analysed with the Mann-Whitney test. The frequency of Candida-positive organ fragments was determined using contingency table analysis and Fisher's exact test. Linear regression analysis was used to correlate the tumoral progression with fungal installation and dissemination. All other data were analysed using one-way ANOVA with a Tukey-Kramer post-test [17] . All statistical analysis was performed in GraphPad InStat version 3.0 for Windows (GraphPad Software, San Diego, CA, USA) and the statistical significance level established was P < 0.05.
Results

Tumour implantation
One week after the introduction of Ehrlich ascite tumour cells into the subcutaneous tissue of mice, a firm palpable whitish mass that was relatively mobile with little adherence to the adjacent tissues developed at the site of inoculation. This tumour showed continuous and progressive growth that resulted in animal death approximately 28 days after implantation.
Fungal installation and dissemination
CTL and TBM groups
Fungi were not present in samples from uninoculated animals (CTL and TBM).
Ca-CTL group
Ca-CTL mice had acute systemic candidiasis that compromised the site of inoculation and the following organs: spleen, liver and kidneys; the spleen was the most affected organ. After 72 h, the number of fungi in the peritoneal cavity ( Fig. 1 ) and viscera significantly decreased (P < 0.05), which suggests that these mice could resolve the infection ( Fig. 2A) .
Ca-TBM group
In contrast to Ca-CTL mice, Ca-TBM mice had a lower number of fungi in the peritoneum on day 7 of tumour progression (Fig. 1A) and a lower frequency of Candidapositive organs 24 h after fungal inoculation ( Fig. 2A) . At 72 h, fungi were no longer detected (Figs. 1A and  2A ). Compared to Ca-CTL mice, it is evident that the neoplastic condition significantly altered the host's response to Candida infection.
On day 14 of tumour progression, the Ca-TBM mice exhibited a similar pattern of infection in the peritoneum and organs to Ca-CTL mice at 24 h post-infection (Figs. 1B and 2B) . Although the burden of fungi in the peritoneum was similar to that of Ca-CTL mice at 72 h (Fig. 1B) , the spleen of those animals was more affected (Fig. 2B) .
There was a significant exacerbation of Candida infection 72 h after fungi inoculation in Ca-TBM mice on day 21 of tumour progression; the mice had increased numbers of CFUs in the peritoneal cavity fluid (Fig. 1C) and a larger number of Candida-positive organ samples than the Ca-CTL group (Fig. 2C) . Thus, at the end of the experiment, C. albicans dissemination was more extensive in tumour-bearing animals than in non-TBM.
Evaluation of macrophage activity
Ca-CTL group
Peritoneal macrophages of Ca-CTL mice always exhibited higher production of H 2 O 2 , NO and TNF-a than animals free of fungi and tumours (CTL) (Fig. 3) .
TBM group
Macrophages from TBM had similar NO production compared to the CTL group throughout the experiment (Fig. 4B) . Similarly, the Ca-TBM mice also exhibited basal NO production (data not shown).
In contrast, macrophages from day 7 TBM had significantly increased H 2 O 2 production (Fig. 4A ) and TNF-a release (Fig. 4C ). After this period, H 2 O 2 and TNF-a (C) Ca-BTM on day 21 of tumour progression. Data are expressed as the mean ± SEM of colony-forming units (CFU). *P < 0.05, **P < 0.01, n = 4 (each group evaluated). Mann-Whitney test. levels decreased. Interestingly, H 2 O 2 production in peritoneal macrophages from day 21 TBM rebounded to significantly higher levels (Fig. 4A) .
Ca-TBM group
Macrophages exhibited significantly higher levels of H 2 O 2 and TNF-a during Candida infection in the presence of tumours (7 days) when compared with the Ca-CTL and TBM groups (Figs. 5A and 6A) ; the ability of the macrophages to respond to the fungal infection and tumour remained unchanged.
At 24 h after Candida inoculation, Ca-TBM (14 days) macrophages produced more H 2 O 2 and TNFa when compared with the TBM group in mice with 14-day-old tumours (Figs. 5B and 6B), which suggests that the Ca-TBM group was still able to respond to fungal infection. At 72 h after Candida infection, macrophages from Ca-TBM produced less H 2 O 2 than the Ca-CTL group, although the TNF-a levels were unchanged compared to the Ca-CTL and TBM groups (Figs. 5B and 6B ). This demonstrates that Ca-TBM mice had a decreased capacity to respond to Candida infection by 72 h.
The production of H 2 O 2 and TNF-a was unchanged in Ca-TBM mice with 21-day-old tumours (Figs. 5C and 6C). This suggests that progression of the infection, and not the tumoral mass itself, impairs the ability of macrophages to respond to infection.
Discussion
Although it has been reported that neoplastic tissues are capable of causing immunological degeneration [18] , the mechanisms involved in this process have not been fully clarified. It has been suggested that both the fungus [19] and the tumour factors [20, 21] may depress the ability of macrophages to carry out phagocytosis and lysis, which could facilitate the development of infections, as a consequence.
Similar to other published studies using other experimental models [22] [23] [24] [25] , we observed that i.p. inoculation of C. albicans into tumour-free Swiss mice (Ca-CTL) resulted in acute systemic infection that tended towards resolution by 72 h p.i. The same infection pattern was observed in Ca-TBM until day 7 of tumour progression.
After this period, the TBM were more susceptible to infection.
Similar to previously published studies [26, 27] , we observed that peritoneal macrophages from C. albicansinfected mice produced increased levels of NO. However, the tumour state did not affect NO production by itself, as the TBM and Ca-TBM groups produced a similar quantity of NO as CTL mice. Naama et al. [28] demonstrated that upon fungal challenge, TBM produced a similar quantity of NO as healthy control mice, which Figure 3 Evaluation of macrophage activity in Candida albicans-infected mice (Ca-CTL group). Tumour-free mice were inoculated i.p. with C. albicans and the macrophage activity was evaluated at 24 and 72 h after fungal inoculation (Ca-CTL, white striped box). Naïve mice were used as control group (CTL, white box). suggests that tumour presence negatively influences the production of NO. In our study, macrophages from infected mice with 7-day-old tumours produced basal levels of NO and were still able to eliminate fungi, which suggests that NO does not significantly contribute to the clearance of Candida. Balish et al. [29] demonstrated that NO was not essential for killing C. albicans using NO-deficient animals.
In addition to NO, phagocytic cells of the host can also use reactive oxygen species such as H 2 O 2 , as a part of their arsenal for neutralizing Candida [30] . Therefore, there are other mechanisms available for clearing Candida infection, even if macrophages from tumour-bearing hosts are impaired in their ability to produce NO [29] . This is consistent with our findings concerning H 2 O 2 .
In this study, we demonstrated that peritoneal macrophages from Candida-infected animals always exhibited higher levels of this metabolite than macrophages from control animals. We observed that this phenomenon also occurred in peritoneal macrophages from TBM, regardless of the presence or absence of Candida. Increased H 2 O 2 production was sustained through day seven of tumour growth and coincided with the fast clearance of the fungal burden in infected mice. These data demonstrate that there was an increase in H 2 O 2 release at the beginning of the neoplastic progression, but after this period, H 2 O 2 production decreased and the infection spread. Our findings are consistent with those described by Okawa et al. [7] , who verified that the C. albicans load in sarcoma-bearing mice was related to the levels of oxygen metabolites released by polymorphonuclear cells.
The dual behaviour of the peritoneal macrophages from the Ca-TBM group against Candida suggested that the tumour and ⁄ or its products may have modulated the ability of the macrophages to clear Candida from a distance. According to Elgert et al. [18] , circulating factors derived from tumours, such as cytokines and ⁄ or tumour cell-membrane debris, were able to activate distal macrophages to produce cytotoxic and suppressor molecules. Confirming these data, we observed this picture was associated with TNF-a levels. For instance, at the beginning of tumour progression, mice showed large quantities of TNF-a and the fungal clearance index was high; at the end of the process, this was inverted (i.e. decrease in H 2 O 2 and TNF-a levels and a high fungal load). Therefore, tumour environment could affect the production of macrophage-derived cytokines and consequently the host's resistance to opportunistic infections [7] . Studies are underway in our laboratory to evaluate the role of other cytokines in this process.
It is possible that we have worked with macrophages from the tumour site (TAMs), as Bhaumik and Khar [9] have reported that macrophages traffic between the peritoneum and neoplastic tissues. Mitra et al. [31] demonstrated that macrophages migrated to regional lymph nodes and the peritoneum after ingesting antigens from regressive tumour tissue. In the peritoneal cavity, these cells become activated. This event occurs between days 2 and 5 following tumoral implantation and is coincident with tumour regression.
However, the Ehrlich tumour progressed in the present study, even though there was elevated H 2 O 2 and TNF-a production at the beginning of tumour growth (7 days). This progression was associated with a drastic increase in the production of H 2 O 2 and TNF-a. Working with several human tumour cell lines, Kuang et al. [21] described that factors derived from tumours (including hyaluronan fragments) could induce the transitory activation of monocytes and their subsequent development with suppressor activities. Our results are consistent with those findings, including the Ehrlich solid tumour that was capable of promoting the development of immunosuppressive macrophages after triggering a transient early protective response. Therefore, our results provide strong evidence that solid tumour development can interfere in the host's response to infection with C. albicans. This can be attributed to tumour interference in the production of reactive toxic metabolites by peritoneal macrophages that are located away from the tumour development site, thus creating conditions that favour the progression of both the solid tumour and the fungal infection. 
